Kyrgyzstan vs Turkey: HIV-positive TB patients on ART (antiretroviral therapy)
Kyrgyzstan
85.0%
in 2024
Turkey
85.0%
in 2024
Kyrgyzstan rank
106th
Turkey rank
106th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Kyrgyzstan
- Turkey
How they compare
Kyrgyzstan currently reports 85.0% against 85.0% in Turkey, a difference of 0.0%.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Turkey ahead.
Kyrgyzstan ranks 106th and Turkey ranks 106th of 144 countries.
Turkey has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.7% | 77.9% | 11.2% | Turkey |
| 2020s | 73.8% | 76.8% | 3.0% | Turkey |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Kyrgyzstan or Turkey?
- Kyrgyzstan, at 85.0% against 85.0% in Turkey as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Kyrgyzstan and Turkey?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Turkey?
- 15 years are reported by both, from 2010 to 2024.
- How do Kyrgyzstan and Turkey rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Kyrgyzstan ranks 106th and Turkey ranks 106th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.